Cargando…
Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder
Many patients with opioid use disorder do not have successful outcomes during treatment but the underlying reasons are not well understood. An OPRD1 variant (rs678849) was previously associated with methadone and buprenorphine efficacy in African-Americans with opioid use disorder. The objective of...
Autores principales: | Crist*, Richard. C., Phillips, Karran. A., Furnari, Melody. A., Moran, Landhing. M., Doyle, Glenn. A., McNicholas, Laura. F., Cornish, James. W., Kampman, Kyle. M., Preston, Kenzie. L., Berrettini, Wade. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486881/ https://www.ncbi.nlm.nih.gov/pubmed/30368523 http://dx.doi.org/10.1038/s41397-018-0065-x |
Ejemplares similares
-
A brief review of the genetics and pharmacogenetics of opioid use disorders
por: Berrettini, Wade
Publicado: (2017) -
Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European American females
por: Clarke, Toni-Kim, et al.
Publicado: (2013) -
Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder
por: Kranzler, Henry R., et al.
Publicado: (2021) -
A polymorphism in the OPRM1 3′ untranslated region is associated with methadone efficacy in treating opioid dependence
por: Crist, Richard C., et al.
Publicado: (2016) -
Correction to: Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder
por: Kranzler, Henry R., et al.
Publicado: (2021)